• Je něco špatně v tomto záznamu ?

Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth

JS. Zhao, S. Shi, HY. Qu, Z. Keckesova, ZJ. Cao, LX. Yang, X. Yu, L. Feng, Z. Shi, J. Krakowiak, RY. Mao, YT. Shen, YM. Fan, TM. Fu, C. Ye, D. Xu, X. Gao, J. You, W. Li, T. Liang, Z. Lu, YX. Feng

. 2022 ; 4 (2) : 239-253. [pub] 20220210

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019446

Tumors can reprogram the functions of metabolic enzymes to fuel malignant growth; however, beyond their conventional functions, key metabolic enzymes have not been found to directly govern cell mitosis. Here, we report that glutamine synthetase (GS) promotes cell proliferation by licensing mitotic progression independently of its metabolic function. GS depletion, but not impairment of its enzymatic activity, results in mitotic arrest and multinucleation across multiple lung and liver cancer cell lines, patient-derived organoids and xenografted tumors. Mechanistically, GS directly interacts with the nuclear pore protein NUP88 to prevent its binding to CDC20. Such interaction licenses activation of the CDC20-mediated anaphase-promoting complex or cyclosome to ensure proper metaphase-to-anaphase transition. In addition, GS is overexpressed in human non-small cell lung cancer and its depletion reduces tumor growth in mice and increases the efficacy of microtubule-targeted chemotherapy. Our findings highlight a moonlighting function of GS in governing mitosis and illustrate how an essential metabolic enzyme promotes cell proliferation and tumor development, beyond its main metabolic function.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019446
003      
CZ-PrNML
005      
20220804135651.0
007      
ta
008      
220720s2022 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s42255-021-00524-2 $2 doi
035    __
$a (PubMed)35145325
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Zhao, Jiang-Sha $u Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. zhaojsh@zju.edu.cn $u Cancer Center, Zhejiang University, Hangzhou, China. zhaojsh@zju.edu.cn $1 https://orcid.org/0000000236429269
245    10
$a Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth / $c JS. Zhao, S. Shi, HY. Qu, Z. Keckesova, ZJ. Cao, LX. Yang, X. Yu, L. Feng, Z. Shi, J. Krakowiak, RY. Mao, YT. Shen, YM. Fan, TM. Fu, C. Ye, D. Xu, X. Gao, J. You, W. Li, T. Liang, Z. Lu, YX. Feng
520    9_
$a Tumors can reprogram the functions of metabolic enzymes to fuel malignant growth; however, beyond their conventional functions, key metabolic enzymes have not been found to directly govern cell mitosis. Here, we report that glutamine synthetase (GS) promotes cell proliferation by licensing mitotic progression independently of its metabolic function. GS depletion, but not impairment of its enzymatic activity, results in mitotic arrest and multinucleation across multiple lung and liver cancer cell lines, patient-derived organoids and xenografted tumors. Mechanistically, GS directly interacts with the nuclear pore protein NUP88 to prevent its binding to CDC20. Such interaction licenses activation of the CDC20-mediated anaphase-promoting complex or cyclosome to ensure proper metaphase-to-anaphase transition. In addition, GS is overexpressed in human non-small cell lung cancer and its depletion reduces tumor growth in mice and increases the efficacy of microtubule-targeted chemotherapy. Our findings highlight a moonlighting function of GS in governing mitosis and illustrate how an essential metabolic enzyme promotes cell proliferation and tumor development, beyond its main metabolic function.
650    _2
$a zvířata $7 D000818
650    12
$a nemalobuněčný karcinom plic $7 D002289
650    _2
$a proteiny buněčného cyklu $x metabolismus $7 D018797
650    _2
$a proliferace buněk $7 D049109
650    _2
$a glutaminsynthetasa $7 D005974
650    _2
$a lidé $7 D006801
650    _2
$a licence $7 D008004
650    12
$a nádory plic $7 D008175
650    _2
$a myši $7 D051379
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Shi, Shuo $u Shanghai Advanced Institute of Immunochemical Studies, ShanghaiTech University, Shanghai, China
700    1_
$a Qu, Hai-Yan $u Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China
700    1_
$a Keckesova, Zuzana $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Cao, Zi-Jian $u Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China
700    1_
$a Yang, Li-Xian $u Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China
700    1_
$a Yu, Xiaofu $u Department of Thoracic Radiotherapy, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China
700    1_
$a Feng, Limin $u Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China
700    1_
$a Shi, Zhong $u Department of Medical Oncology, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China
700    1_
$a Krakowiak, Joanna $u Department of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center Houston, Houston, TX, USA
700    1_
$a Mao, Ruo-Ying $u Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China
700    1_
$a Shen, Yi-Tong $u Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China
700    1_
$a Fan, Yu-Meng $u Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China
700    1_
$a Fu, Tian-Min $u Department of Biological Chemistry and Pharmacology, College of Medicine, The Ohio State University, Ohio, OH, USA $1 https://orcid.org/0000000262811752
700    1_
$a Ye, Cunqi $u Life Sciences Institute, Zhejiang University, Hangzhou, China
700    1_
$a Xu, Daqian $u Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China $u Cancer Center, Zhejiang University, Hangzhou, China
700    1_
$a Gao, Xiaofei $u School of Life Sciences, Westlake University, Hangzhou, China
700    1_
$a You, Jia $u School of Life Sciences, Westlake University, Hangzhou, China
700    1_
$a Li, Wenbo $u Department of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center Houston, Houston, TX, USA $u MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas, Houston, TX, USA
700    1_
$a Liang, Tingbo $u Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. liangtingbo@zju.edu.cn $u Cancer Center, Zhejiang University, Hangzhou, China. liangtingbo@zju.edu.cn
700    1_
$a Lu, Zhimin $u Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. zhiminlu@zju.edu.cn $u Cancer Center, Zhejiang University, Hangzhou, China. zhiminlu@zju.edu.cn
700    1_
$a Feng, Yu-Xiong $u Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. yxfeng@zju.edu.cn $u Cancer Center, Zhejiang University, Hangzhou, China. yxfeng@zju.edu.cn $1 https://orcid.org/0000000290864448
773    0_
$w MED00207066 $t Nature metabolism $x 2522-5812 $g Roč. 4, č. 2 (2022), s. 239-253
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35145325 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135645 $b ABA008
999    __
$a ok $b bmc $g 1822869 $s 1170689
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 4 $c 2 $d 239-253 $e 20220210 $i 2522-5812 $m Nature metabolism $n Nat Metab $x MED00207066
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace